Sudoscan and Withings Participation at the 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
We are excited to announce that Sudoscan and Withings will be participating in the 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) from March 19th to 22nd, 2025, at the RAI Amsterdam – Entrance K, Europaplein 24, 1078 GZ Amsterdam, The Netherlands. The conference will also be available online through the Interactive Program and the sessions will be held in English. Join us at stand 25 to discover how our technological device is shaping the future of diabetes care.
Spotlight on the International Conference on ATTD
ATTD is a unique diabetes conference where clinicians and scientists present, discuss, and exchange insights on the most rapidly evolving areas of diabetes technologies and treatments. This international event gathers a community of experts, diabetes care providers, clinicians, researchers, investors, industry professionals, reimbursement authorities, and people with diabetes.
The 2025 edition will feature discussions on groundbreaking topics such as:
● Digital clinics
● Decision support systems/advisors
● Big data and artificial intelligence-based decision support systems
● Glucose sensors
● Closed–and open-loop systems
● Artificial pancreas
● Devices for diabetes prevention
● New insulins and medications
● Insulin pumps
If you want to learn more about the scientific program of the 2025 ATTD Conference, click here.
Sudoscan and Withings will attend the 2025 ATTD Conference
Sudoscan is proud to participate, in collaboration with Withings, in this prestigious conference, showcasing our innovative solution for diabetes management.
Since 2021, Sudoscan has been part of the Withings group, a pioneer in connected health devices. Withings’ wide range of smart health devices including connected scales, smart blood pressure monitors, and activity trackers complements Sudoscan’s technology, offering new possibilities for managing diabetes care.
Indeed, Sudoscan’s technology provides a fast, non-invasive evaluation of sudomotor function, assisting healthcare professionals in the early detection of diabetic neuropathy. With over 23 years of research and numerous scientific studies validating its efficacy, Sudoscan plays a crucial role in identifying diabetic complications at an early stage.
For more studies on the efficacy of Sudoscan’s technology in diabetes management, visit our publications page.
Come and see Sudoscan at stand 25
We invite you to visit stand 25 at the 2025 ATTD Conference to discover how Sudoscan’s technology contributes to diabetes management and prevention. By joining us, you will have the opportunity to:
● Learn how Sudoscan contributes to the early identification of diabetic complications.
● Witness live demonstrations showcasing the device’s performance and user-friendly design.
● Connect with our experts to discuss how Sudoscan can seamlessly integrate into clinical workflows to optimize patient outcomes.
Don’t miss this opportunity to explore how Sudoscan and Withings are transforming diabetes care through technological innovation. We look forward to welcoming you to the 2025 ATTD Conference in Amsterdam! See you at stand 25!
To book your ticket and access the full program, please visit the ATTD 2025 official website.
